EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C32H34N2O12 |
| Net Charge | 0 |
| Average Mass | 638.626 |
| Monoisotopic Mass | 638.21117 |
| SMILES | COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N2CCOCC2C#N)[C@H](O)[C@H](C)O1 |
| InChI | InChI=1S/C32H34N2O12/c1-14-27(37)18(34-6-7-44-13-15(34)11-33)8-22(45-14)46-20-10-32(42,21(36)12-35)9-17-24(20)31(41)26-25(29(17)39)28(38)16-4-3-5-19(43-2)23(16)30(26)40/h3-5,14-15,18,20,22,27,35,37,39,41-42H,6-10,12-13H2,1-2H3/t14-,15?,18-,20-,22-,27+,32-/m0/s1 |
| InChIKey | YIMDLWDNDGKDTJ-QLKYHASDSA-N |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) has functional parent doxorubicin (CHEBI:28748) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) has role antineoplastic agent (CHEBI:35610) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) is a morpholines (CHEBI:38785) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) is a nitrile (CHEBI:18379) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) is a primary α-hydroxy ketone (CHEBI:139590) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) is a tertiary α-hydroxy ketone (CHEBI:139592) |
| IUPAC Name |
|---|
| (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-(3-cyanomorpholin-4-yl)-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| Synonyms | Source |
|---|---|
| 3'-(3-Cyano-4-morpholinyl)-3'-deamino-adriamycin | ChemIDplus |
| 3'-DESAMINO-3'-(3-CYANO-4-MORPHOLINYL)-DOXORUBICIN | PDBeChem |
| Cyanomorpholinoadriamycin | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| CMD | PDBeChem |
| Registry Numbers | Sources |
|---|---|
| Beilstein:6050053 | Beilstein |
| CAS:88254-07-3 | ChemIDplus |